Modulation of neutrophil-to-lymphocyte ratio and gut microbiome balance in astronauts: potential benefits of novel beta-glucans during space missions.
Saved in:
| Title: | Modulation of neutrophil-to-lymphocyte ratio and gut microbiome balance in astronauts: potential benefits of novel beta-glucans during space missions. |
|---|---|
| Authors: | Ikewaki N; Department of Medical Life Science, Kyushu University of Medical Sciences, Nobeoka, Japan.; Institute of Immunology, Junsei Educational Institute, Nobeoka, Japan., Ichiyama K; Antony Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co., Ltd., Kofu, Japan., Senthilkumar R; Antony Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co., Ltd., Kofu, Japan., Preethy S; Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India., Abraham SJK; Antony Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co., Ltd., Kofu, Japan.; Centre for Advancing Clinical Research (CACR), University of Yamanashi-School of Medicine, Chuo, Japan.; Mary Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India.; Research & Development (R & D) Department, Sophy Inc., Niyodogawa, Japan.; Levy-Jurgen Transdisciplinary Exploratory (LJTE), Global Niche Corp., Wilmington, DE, United States.; Haraguchi-Parikumar Advanced Remedies (HARP) & Cherian-Yoshii Translational Exemplary (CYTE), SoulSynergy Ltd., Phoenix, Mauritius. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 03; Vol. 16, pp. 1538147. Date of Electronic Publication: 2025 Mar 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
